These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22200615)

  • 1. Inflammation-induced lymph node lymphangiogenesis is reversible.
    Mumprecht V; Roudnicky F; Detmar M
    Am J Pathol; 2012 Mar; 180(3):874-879. PubMed ID: 22200615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography.
    Mumprecht V; Honer M; Vigl B; Proulx ST; Trachsel E; Kaspar M; Banziger-Tobler NE; Schibli R; Neri D; Detmar M
    Cancer Res; 2010 Nov; 70(21):8842-51. PubMed ID: 20978206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo imaging of lymph node lymphangiogenesis by immuno-positron emission tomography.
    Mumprecht V; Detmar M
    Methods Mol Biol; 2013; 961():129-40. PubMed ID: 23325639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced lymphatic sinus hyperplasia in sentinel lymph nodes by VEGF-C as the earliest premetastatic indicator.
    Liersch R; Hirakawa S; Berdel WE; Mesters RM; Detmar M
    Int J Oncol; 2012 Dec; 41(6):2073-8. PubMed ID: 23076721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tumor formation and metastasis by a monoclonal antibody against lymphatic vessel endothelial hyaluronan receptor 1.
    Hara Y; Torii R; Ueda S; Kurimoto E; Ueda E; Okura H; Tatano Y; Yagi H; Ohno Y; Tanaka T; Masuko K; Masuko T
    Cancer Sci; 2018 Oct; 109(10):3171-3182. PubMed ID: 30058195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
    Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
    Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein inhibits lymphangiogenesis and resultant lymph node metastasis of squamous cell carcinoma in mice.
    Sasaki T; Motoyama S; Sato Y; Yoshino K; Matsumoto G; Minamiya Y; Saito H; Murata K; Ogawa J
    Surgery; 2013 Nov; 154(5):1087-92. PubMed ID: 23859309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New insights into the molecular mechanisms of lymphangiogenesis and pathophysiology].
    Hirakawa S
    Yakugaku Zasshi; 2012; 132(2):211-4. PubMed ID: 22293702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis.
    Hirakawa S; Kodama S; Kunstfeld R; Kajiya K; Brown LF; Detmar M
    J Exp Med; 2005 Apr; 201(7):1089-99. PubMed ID: 15809353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging tumor-induced sentinel lymph node lymphangiogenesis with LyP-1 peptide.
    Zhang F; Niu G; Lin X; Jacobson O; Ma Y; Eden HS; He Y; Lu G; Chen X
    Amino Acids; 2012 Jun; 42(6):2343-51. PubMed ID: 21769497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ectodomain Shedding of Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE-1) Is Induced by Vascular Endothelial Growth Factor A (VEGF-A).
    Nishida-Fukuda H; Araki R; Shudou M; Okazaki H; Tomono Y; Nakayama H; Fukuda S; Sakaue T; Shirakata Y; Sayama K; Hashimoto K; Detmar M; Higashiyama S; Hirakawa S
    J Biol Chem; 2016 May; 291(20):10490-500. PubMed ID: 26966180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor lymphangiogenesis and melanoma metastasis.
    Rinderknecht M; Detmar M
    J Cell Physiol; 2008 Aug; 216(2):347-54. PubMed ID: 18481261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of the lymphatic vasculature in cancer and inflammation: new opportunities for in vivo imaging and drug delivery.
    Proulx ST; Luciani P; Dieterich LC; Karaman S; Leroux JC; Detmar M
    J Control Release; 2013 Dec; 172(2):550-7. PubMed ID: 23665257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor metastasis and the lymphatic vasculature.
    Sleeman JP; Thiele W
    Int J Cancer; 2009 Dec; 125(12):2747-56. PubMed ID: 19569051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.
    Mattila MM; Ruohola JK; Karpanen T; Jackson DG; Alitalo K; Härkönen PL
    Int J Cancer; 2002 Apr; 98(6):946-51. PubMed ID: 11948478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of lymphangiogenesis in non-small cell lung cancer and its prognostic value.
    Sun JG; Wang Y; Chen ZT; Zhuo WL; Zhu B; Liao RX; Zhang SX
    J Exp Clin Cancer Res; 2009 Feb; 28(1):21. PubMed ID: 19216806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic vessel activation in cancer.
    Das S; Skobe M
    Ann N Y Acad Sci; 2008; 1131():235-41. PubMed ID: 18519976
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.